Company / Free Cash Flow
KYNTRA BIO, INC. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$138.3M
FY2025
5-year range
-$317.5M / $77.6M
FY2021-FY2025
Trend
+56.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow returned to growth in FY2025 after 2 years of decline, reaching -$138M.
Based on SEC 10-K filings.
-$138M in FY2025.
Declined from -$87M to -$138M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 56.5% year-over-year.
- Peak free cash flow was recorded in FY2022.
- Lowest free cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$138.3M | +56.5% |
| FY2024 | -$317.5M | -263.2% |
| FY2023 | -$87.4M | -212.6% |
| FY2022 | $77.6M | +191.9% |
| FY2021 | -$84.5M | -0.4% |
| FY2020 | -$84.2M | -12.2% |
| FY2019 | -$75.0M | -1381.0% |
| FY2018 | $5.9M | +128.5% |
| FY2017 | -$20.5M | -243.7% |
| FY2016 | $14.3M | -25.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026